Physician profile
Robert S Marks
NPI 1447450796
$15,088.92
in general payments reported to CMS, 2019-2025
42 companies · $2,591 in 2025
The $2,591 reported for 2025 was more than what 86% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $766 · 2020: $155 · 2021: $1,022 · 2022: $1,579 · 2023: $2,707 · 2024: $6,270 · 2025: $2,591.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Travel and Lodging: $872 · Gift: $15.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,681.04 |
| Travel and Lodging | $872.32 |
| Gift | $15.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,334.83 | 2019-2025 | Intracept, Wavewriter Alpha Prime 16, General - Pain Management |
| Abbott Laboratories | $2,973.25 | 2021-2025 | Proclaim, Penta, Eterna |
| Medtronic, INC. | $2,691.34 | 2022-2025 | Intellis Adaptivestim, Inceptiv, Synchromedii |
| Abbvie INC. | $866.87 | 2022-2025 | |
| Spinal Simplicity, LLC | $651.48 | 2023-2025 | Ha Minuteman G3-R |
| Nalu Medical, INC. | $579.22 | 2023-2024 | Nalu Neurostimulation System |
| Stryker Corporation | $453.63 | 2024 | Spinejack, Optablate |
| Collegium Pharmaceutical, INC. | $430.02 | 2019-2025 | Belbuca, Xtampza |
| Globus Medical, INC. | $429.73 | 2025 | Senza |
| Biodelivery Sciences International, INC. | $331.36 | 2019-2021 | |
| Pfizer INC. | $272.08 | 2019-2024 | |
| Allergan, INC. | $252.03 | 2021-2022 | |
| Grt US Holding, INC. | $168.89 | 2021-2022 | |
| Scilex Pharmaceuticals INC. | $159.01 | 2019-2024 | Ztlido |
| Genesys Orthopedics Systems, L.L.C. | $144.54 | 2024 | Sacroiliac Joint Fusion System |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Marks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.